[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Article
November 16, 1984

Choice of Psychotropic Drugs

Author Affiliations

Tufts University School of Medicine Boston

JAMA. 1984;252(19):2702. doi:10.1001/jama.1984.03350190012010
Abstract

To the Editor.—  I would like to clarify a statement in my previous letter, in which I described the anxiolytic alprazolam (Xanax) as "exceptional."1 I meant to convey that, unlike conventional antianxiety agents, alprazolam seems to have antidepressant properties.2 Indeed, its use in anxious, depressed patients may be accompanied by neuroendocrine changes suggestive of recovery from depression.3

References
1.
Pies R:  Choice of psychotropic drugs .  JAMA 1984; 252:765.Crossref
2.
Feighner JP, Aden GC, Fabre LF, et al:  Comparison of alprazolam, imipramine, and placebo in the treatment of depression .  JAMA 1983;249:3057-3064.Crossref
3.
Pies R:  Alprazolam for panic disorder and depression .  Am J Psychiatry 1983;140:640.
×